Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 2/20 | 0.42 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.41 |
| ▸ | FABP7 | O15540 | 1/20 | 0.41 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13124061 | 0.90 | KMT2A (0.67) | KMT2AEPHX2TLR2 | |
| SCHEMBL92796 | 0.88 | KMT2A (0.66) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL31419531 | 0.88 | KMT2A (0.66) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL18290276 | 0.87 | KMT2A (0.65) | KMT2AEPHX2CASP3FABP5FABP7 | |
| Hydrochloric Acid SCHEMBL31419532 | 0.87 | KMT2A (0.64) | KMT2AEPHX2CASP3TLR2FABP5 | |
| SCHEMBL3515002 | 0.86 | KMT2A (0.68) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL4557899 | 0.86 | KMT2A (0.68) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL28429395 | 0.86 | KMT2A (0.71) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL31270657 | 0.86 | KMT2A (0.71) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL12665707 | 0.85 | KMT2A (0.67) | KMT2AEPHX2CASP3FABP5FABP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2368908-A2 | Anti- angiogenic compounds | CovX Technologies Ireland Limited (IE) | 2011-09-28 | — | — | EP | disclosed |
| EP-2292248-A2 | Anti-angiogenic compounds | CovX Technologies Ireland Limited (IE) | 2011-03-09 | — | — | EP | disclosed |